[1]
Pedrón VT, Varani AP, Bettler B, Balerio GN. GABA(B) receptors modulate morphine antinociception: Pharmacological and genetic approaches. Pharmacology, biochemistry, and behavior. 2019 May:180():11-21. doi: 10.1016/j.pbb.2019.02.015. Epub 2019 Mar 6
[PubMed PMID: 30851293]
[2]
Kondziella D. The Top 5 Neurotransmitters from a Clinical Neurologist's Perspective. Neurochemical research. 2017 Jun:42(6):1767-1771. doi: 10.1007/s11064-016-2101-z. Epub 2016 Nov 8
[PubMed PMID: 27822666]
Level 3 (low-level) evidence
[3]
Olsen RW. GABA(A) receptor: Positive and negative allosteric modulators. Neuropharmacology. 2018 Jul 1:136(Pt A):10-22. doi: 10.1016/j.neuropharm.2018.01.036. Epub 2018 Jan 31
[PubMed PMID: 29407219]
[4]
Südhof TC. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron. 2013 Oct 30:80(3):675-90. doi: 10.1016/j.neuron.2013.10.022. Epub
[PubMed PMID: 24183019]
[5]
Leinekugel X, Khalilov I, McLean H, Caillard O, Gaiarsa JL, Ben-Ari Y, Khazipov R. GABA is the principal fast-acting excitatory transmitter in the neonatal brain. Advances in neurology. 1999:79():189-201
[PubMed PMID: 10514814]
Level 3 (low-level) evidence
[7]
Khanna A, Walcott BP, Kahle KT. Limitations of Current GABA Agonists in Neonatal Seizures: Toward GABA Modulation Via the Targeting of Neuronal Cl(-) Transport. Frontiers in neurology. 2013:4():78. doi: 10.3389/fneur.2013.00078. Epub 2013 Jun 25
[PubMed PMID: 23805124]
[8]
Wang Q, Ren L, Wan Y, Prud'homme GJ. GABAergic regulation of pancreatic islet cells: Physiology and antidiabetic effects. Journal of cellular physiology. 2019 Sep:234(9):14432-14444. doi: 10.1002/jcp.28214. Epub 2019 Jan 28
[PubMed PMID: 30693506]
[9]
Tong Y. Seizures caused by pyridoxine (vitamin B6) deficiency in adults: A case report and literature review. Intractable & rare diseases research. 2014 May:3(2):52-6. doi: 10.5582/irdr.2014.01005. Epub
[PubMed PMID: 25343127]
Level 3 (low-level) evidence
[10]
Raymond LA. Striatal synaptic dysfunction and altered calcium regulation in Huntington disease. Biochemical and biophysical research communications. 2017 Feb 19:483(4):1051-1062. doi: 10.1016/j.bbrc.2016.07.058. Epub 2016 Jul 14
[PubMed PMID: 27423394]
[11]
Hammond JB, Ahmad F. Hepatic encephalopathy and role of antibenzodiazepines. American journal of therapeutics. 1998 Jan:5(1):33-6
[PubMed PMID: 10099035]
[12]
Termsarasab P, Thammongkolchai T, Frucht SJ. Medical treatment of dystonia. Journal of clinical movement disorders. 2016:3():19. doi: 10.1186/s40734-016-0047-6. Epub 2016 Dec 19
[PubMed PMID: 28031858]
[13]
Yamada KA, Norman WP, Hamosh P, Gillis RA. Medullary ventral surface GABA receptors affect respiratory and cardiovascular function. Brain research. 1982 Sep 23:248(1):71-8
[PubMed PMID: 6289995]
[14]
Ahnert-Hilger G, Kutay U, Chahoud I, Rapoport T, Wiedenmann B. Synaptobrevin is essential for secretion but not for the development of synaptic processes. European journal of cell biology. 1996 May:70(1):1-11
[PubMed PMID: 8738414]
[15]
Wan Y, Wang Q, Prud'homme GJ. GABAergic system in the endocrine pancreas: a new target for diabetes treatment. Diabetes, metabolic syndrome and obesity : targets and therapy. 2015:8():79-87. doi: 10.2147/DMSO.S50642. Epub 2015 Feb 3
[PubMed PMID: 25678807]
[16]
Korpi ER, Sinkkonen ST. GABA(A) receptor subtypes as targets for neuropsychiatric drug development. Pharmacology & therapeutics. 2006 Jan:109(1-2):12-32
[PubMed PMID: 15996746]
[17]
Jembrek MJ, Vlainic J. GABA Receptors: Pharmacological Potential and Pitfalls. Current pharmaceutical design. 2015:21(34):4943-59
[PubMed PMID: 26365137]